Larson Financial Group »

Oruka Therapeutics shares owned by Larson Financial Group

Quarter-by-quarter ownership of Oruka Therapeutics (ORKA) shares owned by Larson Financial Group from 13F filings

Historical chart of Larson Financial Group investment in Oruka Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Oruka Therapeutics held by Larson Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oruka Therapeutics by Larson Financial Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $211 11 19.27

More positions owned by Larson Financial Group

Spdr Series Trust Portfolio S&p500 (SPLG)
Apple (AAPL)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
American Centy Etf Tr Us Quality Grow (QGRO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Mid Cap Etf (VO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Franklin Templeton Etf Tr Us Mid Cp Mltfct (FLQM)
Capital Group Global Equity SHS (CGGE)
Invesco Exchange Traded Fd T Rafi Us 1000 Etf (PRF)
Ishares Tr Msci Intl Qualty (IQLT)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Broadcom (AVGO)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)

View all positions for Larson Financial Group

Top funds holding Oruka Therapeutics

FMR
VR Adviser
Fairmount Funds Management
Viking Global Investors
Deep Track Capital
BlackRock
Rtw Investments
Vanguard Group
Commodore Capital
Braidwell
venBio Select Advisor
Perceptive Advisors
Franklin Resources
Point72 Asset Management
Polar Capital Holdings

View all funds holding Oruka Therapeutics